Print Issue: May 01, 2008

Novel Anemia Drug Is Safe, Effective

GRAPEVINE, TEX.—Once monthly administration of Hematide, a novel erythropoiesis stimulating agent (ESA), maintains stable hemoglobin (Hb) levels of 11-12 g/dL and is safe and well tolerated long term, according to data presented here at the National Kidney Foundation 2008 Spring Clinical Meetings.

Study: Prostatitis May Increase BPH Risk

Physician-diagnosed prostatitis is associated with 2.4-fold increased risk of a later diagnosis of BPH and a 70% increased risk of requiring later treatment for that condition, according to a study published in Urology (2008;71:475-479).

Narcotics Use Common

Hemodialysis patients frequently use narcotics for chronic pain, a study found. The study of 120 patients showed that 32 of them (26.7%) were receiving narcotics for chronic pain, with hydrocodone, propoxyphene, and oxycodone the most common medications.

PSA Testing Varies by Race

Black men may be getting the message that they are at increased risk of prostate cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention (2008;17:636-644).

Next post in News